• About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations
Shopping cart close
Scilex Holding Scilex Holding
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations

Posts by Ulisses

Home » Articles Posted by Ulisses (Page 25)
17 Mar
Press Release

Scilex Holding Company, a Majority-owned Subsidiary OF Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corp. I

  • March 17, 2022
  • Posted by Ulisses
• Combined company expected to have a pro forma equity value post-money of approximately $1.64 billion, subject to potential adjustment, and with up to $140 million in expected gross proceeds before...

Read more

24 Feb
SEC FIlings

Annual report for fiscal year ending Dec 31, 2021

  • November 17, 2022
  • Posted by Ulisses

Read more

18 Feb
SEC FIlings

Prospectuses and communications, business combinations

  • November 17, 2022
  • Posted by Ulisses

Read more

18 Feb
SEC FIlings

Current report

  • November 17, 2022
  • Posted by Ulisses

Read more

14 Feb
SEC FIlings

Statement of acquisition of beneficial ownership by individuals – Amendment

  • November 17, 2022
  • Posted by Ulisses

Read more

11 Feb
SEC FIlings

Statement of acquisition of beneficial ownership by individuals

  • November 17, 2022
  • Posted by Ulisses

Read more

03 Feb
SEC FIlings

Statement of acquisition of beneficial ownership by individuals

  • November 17, 2022
  • Posted by Ulisses

Read more

02 Feb
SEC FIlings

Statement of acquisition of beneficial ownership by individuals – Amendment

  • November 17, 2022
  • Posted by Ulisses

Read more

10 Jan
SEC FIlings

Statement of acquisition of beneficial ownership by individuals

  • November 17, 2022
  • Posted by Ulisses

Read more

07 Jan
SEC FIlings

Current report

  • November 17, 2022
  • Posted by Ulisses

Read more

«‹2324252627›»
Close
Recent Posts
  • scilex-no-pic
    Henry Ji, PhD
    August 21, 2025 No Comments
  • scilex-no-pic
    Stephen Ma
    August 21, 2025 No Comments
  • scilex-no-pic
    Dorman Followwill 
    August 21, 2025 No Comments
  • Alexander Wu, PhD
    August 21, 2025 No Comments
  • scilex-no-pic
    Jay Chun, MD, PhD
    August 21, 2025 No Comments
scilex-holding-logo-white

Terms of Use  Privacy Policy  Contact

  • Follow us on Facebook
  • Follow us on LinkedIn
  • Contact us by email

©2025 Scilex Holding All Rights Reserved
Scilex Holding Company is the owner of Scilex Pharmaceuticals and Semnur Pharmaceuticals

  • <
  • <
  • <
Scroll To Top Sidebar
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept More info